Orbenin EDC 600 mg suspension intramammaire
Orbenin EDC 600 mg suspension intramammaire
Authorised
- Cloxacillin
Product identification
Medicine name:
Orbenin EDC 600 mg suspension intramammaire
Orbenin EDC 600 mg Suspension zur intramammären Anwendung
Active substance:
- Cloxacillin
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin600.00/milligram(s)1.00Tube
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal24hour
-
Milk36hourThis delay of 36 hours is only valid with cows in dry period for at least 42 days. In case of an early delivery (dry period less than 42 days), the milk is not to be used for human consumption till 44 days after treatment.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Orbenin EDC 24 3.6 g Tube Intramammary suspension
- Orbenin EDC 60 3.6 g Tube Intramammary suspension
- Orbenin EDC 120 3.6 g Tube Intramammary suspension
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
- V 087/91/11/0347
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 17/03/2023
